The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death

Published:2018-03-28 Issue:1 Volume:15 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Söllvander Sofia,Nikitidou Elisabeth,Gallasch Linn,Zyśk Marlena,Söderberg Linda,Sehlin Dag,Lannfelt Lars,Erlandsson Anna

Funder

Vetenskapsrådet

Alzheimerfonden

Åhlén-stiftelsen

Gun och Bertil Stohnes Stiftelse

Magnus Bergvalls Stiftelse

Demensförbundet

Petrus och Augusta Hedlunds Stiftelse

Uppsala Berzelii Center

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-018-1134-4.pdf

Reference60 articles.

1. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535–9.

2. Lee SJ, Nam E, Lee HJ, Savelieff MG, Lim MH. Towards an understanding of amyloid-beta oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev. 2017;46:310–23.

3. Williams TL, Serpell LC. Membrane and surface interactions of Alzheimer's Abeta peptide—insights into the mechanism of cytotoxicity. FEBS J. 2011;278:3905–17.

4. Klyubin I, Walsh DM, Cullen WK, Fadeeva JV, Anwyl R, Selkoe DJ, Rowan MJ. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur J Neurosci. 2004;19:2839–46.

5. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci. 1999;19:8876–84.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapies: A Treasure Trove of Alzheimer's Disease;Current Pharmaceutical Biotechnology;2024-07-19

2. Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease;Acta Pharmaceutica Sinica B;2024-07

3. Die Behandlung der Alzheimer-Krankheit mit Amyloid-Antikörpern;Nervenheilkunde;2024-07

4. Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease;International Journal of Molecular Sciences;2024-04-09

5. Quantitative systems pharmacology‐based exploration of relevant anti‐amyloid therapy challenges in clinical practice;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3